Image enhancement leader, ContextVision, names new CFO, Ann-Charlotte Linderoth and adds Lena Kajland Wilén as director of business development
Stockholm, Sweden – April 23, 2015 –ContextVision, the leader in medical image enhancement technology, is strengthening its management team. In order to maintain a high focus on its ongoing business simultaneously while increasing its focus on new business development, the company has announced two new management team appointments – Ann-Charlotte Linderoth, as Chief Financial Officer and Lena Kajland Wilén, as Director of Business Development.
Linderoth brings 20 years of experience in different financial positions within the medical devices industry to her new role at ContextVision. She was previously ContextVision’s Financial Officer and now replaces former CFO Bengt Hunyadi, who has decided to leave the company to pursue another career.
Linderoth holds a Bachelor of Science in Business Administration and Economics from the University of Stockholm.
Kajland Wilén brings 25 years of experience in the international life science business to her new role, which will largely focus on coordinating and managing business development activities. Prior to ContextVision, she was most recently a marketing and business development consultant. Earlier in her career, she held global marketing and business positions within Pharmacia Ophthalmics, developing brands such as Healon and Xalatan. She later built and headed the marketing function within Aerocrine AB for a decade and for MicroDose mammography within Philips Healthcare.
Kajland Wilén holds a Master in Chemical Engineering from the Royal Institute of Technology and a DIHM in marketing economics from Business School IHM.
“We’re pleased to have Linderoth and Kajland Wilén join our management team and bring several years of experience in the medical industry to ContextVision,” said Anita Tollstadius, ContextVision CEO. “The company is in a very exciting phase of development and we are really happy to have such a strong management team to lead this development.”
For more information about ContextVision’s management team, please visit www.contextvision.com/contextvision/management/.
ContextVision’s technology provides doctors with improved images, which are crucial for accurate diagnosis and treatment. ContextVision is the industry leader in medical imaging analysis and enhancement software, with more than 150,000 installations worldwide through its OEM customers. The company started out as an industry pioneer more than 30 years ago, and is today developing the next generation of medical imaging software for 2D/3D/4D ultrasound, MRI, X-Ray, mammography and CT. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV.